Clinician-prescribed compounded tirzepatide for $695 per 3-month plan (~$232/month) or $350 for a single month — any dose. No membership.
If Hims, Ro, Calibrate, or another telehealth program stopped offering you compounded GLP-1s, SkinnyVIP can continue your care. Compounded tirzepatide and semaglutide, prescribed by licensed clinicians, shipped to your door. Telemedicine in all 50 states.
Not prescribed? Full refund. You only pay if a clinician approves treatment.
See Plans & PricingHims announced a partnership with Novo Nordisk to sell brand-name Wegovy at approximately $499 per month and agreed to stop advertising compounded GLP-1s.
The FDA issued 30 warning letters to telehealth companies citing marketing language regarding compounded GLP-1 products. Many platforms paused their compounded programs in response.
The FDA proposed adding semaglutide, tirzepatide, and liraglutide to the 503B Difficult to Compound list, which would significantly restrict large-volume outsourcing facilities.
Patient-specific compounding under 503A is a different regulatory pathway from large-volume 503B outsourcing. It remains legal and is the pathway SkinnyVIP uses for individualized prescriptions.
For the full breakdown of what happened and what your options are, read our complete guide for patients whose compounded GLP-1 program ended →
Compounded tirzepatide is the most clinically robust option for many patients transitioning from a previous program. Your clinician will recommend a dose based on your history.
Three single months at $350 = $1,050. The 3-Month Plan is $695. You save $355 when you choose 3 months upfront.
Your clinician will recommend a dose range based on your prior history and consultation. The price stays the same when your dose changes. Both plans include clinician consultation, medication, all supplies, and expedited shipping. Compounded tirzepatide is prepared by licensed compounding pharmacies under physician supervision and is not an FDA-approved product.
Many patients transitioning from Hims, Ro, or Calibrate were on compounded semaglutide and want to continue without switching medications. SkinnyVIP prescribes both compounded tirzepatide and compounded semaglutide. Your clinician will discuss which option is clinically appropriate for you during your consultation.
SkinnyVIP listed first; other options listed for context. Pricing reflects May 2026 reporting and patient-facing rates from each provider's public materials.
| Option | Medication | Effective $/mo | Membership Fee |
|---|---|---|---|
| SkinnyVIPThis Site | Compounded tirzepatide or semaglutide | $232 (any dose) | None |
| Hims (now via Novo Nordisk) | Brand Wegovy | ~$499 + membership | Subscription required |
| NovoCare Direct | Brand Wegovy | $349–$499 | Cash-pay direct from manufacturer |
| LillyDirect | Brand Zepbound (vials) | $399–$549 | Cash-pay direct from manufacturer |
| Henry Meds | Compounded tirzepatide | $399–$449 | None separate |
| Mochi Health | Compounded tirzepatide | $349–$449 | $49–$79/mo separate |
Submit the intake form online — it takes about 10 minutes. Include your current medication, dose, weight, and any side effects you've experienced.
Have your most recent prescription label or invoice from your previous program ready (Hims, Ro, Calibrate, or another platform). Your SkinnyVIP clinician may request this to confirm your history.
A licensed SkinnyVIP physician reviews your intake and consults with you to determine whether continuing compounded GLP-1 therapy is clinically appropriate, and at what dose.
The compounding pharmacy ships your medication directly to your door. Total time from intake to medication in hand is typically 3 to 6 business days.
There's nothing to cancel — there's no membership. When your 3-month plan ends, nothing renews automatically. You log in and reorder when you're ready.
Compounded tirzepatide for $695 per 3-month plan (~$232/month) or $350 for a single month — any dose, all-inclusive. Compounded semaglutide also available. No subscription. No contract. No auto-billing.
Start Your ConsultationCompounded tirzepatide and semaglutide are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Compounded tirzepatide and semaglutide are separate products from FDA-approved Mounjaro®, Zepbound® (Eli Lilly), Ozempic®, and Wegovy® (Novo Nordisk). Telemedicine consultations available in all 50 states. Treatment is provided by licensed clinicians. Side effects may occur. Your clinician will review your health history before prescribing.